Heparin, Low-Molecular-Weight

DRUG5 trials

Sponsors

University of Arkansas, National and Kapodistrian University of Athens, University Of Perugia, Azidus Brasil

Conditions

From Surgery in the Two Study Groups.HealthyInfertilityMultiple MyelomaProphylaxis Given for 8±2 Days After Planned LaparoscopicSafety of Extended 4-week Heparin Prophylaxis Compared toSurgery for Colorectal Cancer.The Clinical Benefit Will be Evaluated as the Difference in

Phase 1

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration

CompletedNCT01692171

Azidus BrasilHealthy

Start: 2013-02-28End: 2013-10-31Updated: 2022-10-31

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

CompletedNCT01692158

Azidus BrasilHealthy

Start: 2013-03-31End: 2013-11-30Updated: 2022-10-31

Phase 2

Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation

CompletedNCT01315093

National and Kapodistrian University of AthensInfertility

Start: 2010-11-30End: 2016-06-30Updated: 2018-05-01

Phase 3

ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.

University Of PerugiaFrom Surgery in the Two Study Groups., Prophylaxis Given for 8±2 Days After Planned Laparoscopic, Safety of Extended 4-week Heparin Prophylaxis Compared to +4

Start: 2010-09-30Target: 400Updated: 2012-05-01

Unknown Phase

Effects of Exercise in Combination With Epoetin Alfa

CompletedNCT00577096

University of ArkansasMultiple Myeloma

Start: 2001-10-31End: 2004-06-30Updated: 2015-04-06

Related Papers

A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer

Annals of Surgery2013-11-19195 citations